What about Beijing Tafunuokang Pharmaceutical Biotechnology Co., Ltd.?

Beijing Tafunuokang Pharmaceutical Biotechnology Co., Ltd. is a limited liability company (invested or controlled by a natural person) registered in Beijing with the registered address of 20 17-08-30 and 20 1, Unit 3, Floor 2, Building 3, No.2 Jinghai 4th Road, Beijing Economic and Technological Development Zone.

The unified social credit code/registration number of Beijing Tafunuokang Pharmaceutical Biotechnology Co., Ltd. is 9115ma017awr81. At present, the enterprise is in the state of opening.

The business scope of Beijing Tafunuokang Pharmaceutical Biotechnology Co., Ltd. is: technology development, consultation, service, transfer and promotion; Medical research and experimental development; Health consultation (except for diagnosis and treatment activities subject to approval); Market research; Economic and trade consultation; Enterprise management consulting; Organizing cultural and artistic exchange activities (excluding performances); Undertaking exhibitions; Corporate image planning; Educational consultation (excluding study abroad consultation and intermediary services); Conference services (excluding accommodation); Enterprise marketing planning; Sales of office supplies, sporting goods, electronic products. (Enterprises independently choose business projects and carry out business activities according to law; Projects that must be approved according to law shall, after being approved by the relevant departments, carry out business activities in accordance with the approved contents; Shall not engage in business activities of projects prohibited and restricted by the industrial policies of this Municipality. )。 Within the scope of this province, the registered capital of mobile enterprises belongs to the general.

Beijing Tafunuokang Pharmaceutical Biotechnology Co., Ltd. invested 1 company and 0 branches.

View more information and information of Beijing Tafunuokang Pharmaceutical Biotechnology Co., Ltd. through Baidu Enterprise Credit.